#pharmaceuticals — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pharmaceuticals, aggregated by home.social.
-
AstraZeneca stock falls as investors balk at reported Bristol Myers tie-up
AstraZeneca shares dropped…
#Bristol #UnitedKingdom #UK #GB #England #Headlines #News #Europe #EU #AstraZenecaPLC #BiotechandPharmaceuticals #BreakingNews:Markets #Bristol-MyersSquibbCo #Britain #Business #businessnews #FTSE100 #GileadSciencesInc #GreatBritain #iSharesU.S.PharmaceuticalsETF #Johnson&Johnson #Pharmaceuticals #SpdrS&PBiotechEtf #SpdrS&PPharmaceuticalsEtf #UnitedStates
https://www.europesays.com/uk/1143552/ -
https://www.europesays.com/uk/1143552/ AstraZeneca stock falls as investors balk at reported Bristol Myers tie-up #AstraZenecaPLC #BiotechAndPharmaceuticals #BreakingNews:Markets #Bristol #BristolMyersSquibbCo #Britain #Business #BusinessNews #England #FTSE100 #GileadSciencesInc #GreatBritain #ISharesUSPharmaceuticalsETF #Johnson&Johnson #Pharmaceuticals #SpdrS&PBiotechEtf #SpdrS&PPharmaceuticalsEtf #UK #UnitedKingdom #UnitedStates
-
Business Watch: Japan’s Eneos to acquire TPC; FDA approves twice-rejected melanoma drug
C&EN’s look at the second-quarter earnings of major US and European chemical makers, posted on Friday by…
#EuropeSays #Japan #JP #Business #Biotech #BusinessofJapan #cleantech #Japan'sbusiness #Japanesebusiness #Pharmaceuticals #specialties
https://www.europesays.com/japan/72431/ -
https://www.europesays.com/ie/632105/ New study identifies key pathway for delivering antisense cancer drugs #Antisense #cancer #Cell #CellBiology #DNA #Efficacy #Éire #Enzyme #IE #Ireland #Membrane #Oligonucleotide #Oligonucleotides #PancreaticCancer #pharmaceuticals #Protein #Receptor #Research #Science #Stress #therapy #Tumor
-
Foundayo: Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill
Eli Lilly has won its first approval to sell its weight-loss drug Foundayo in Europe, allowin…
#Europe #EU #BiotechandPharmaceuticals #business #businessnews #ConsumerStaplesSelectSectorSPDRFund #DavidA.Ricks #DefianceDailyTarget2XLongLLYETF #EliLillyandCo #health-care-industry #iSharesBiotechnologyETF #medication #NovoNordiskA/S #Pharmaceuticals #SpdrS&PBiotechEtf #UnitedStates
https://www.europesays.com/europe/113968/ -
https://www.europesays.com/uk/1143111/ Foundayo: Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill #BiotechAndPharmaceuticals #Business #BusinessNews #ConsumerStaplesSelectSectorSPDRFund #DavidARicks #DefianceDailyTarget2XLongLLYETF #EliLillyAndCo #Health #HealthCareIndustry #Healthcare #ISharesBiotechnologyETF #Medication #NovoNordiskA/S #Pharmaceuticals #SpdrS&PBiotechEtf #UK #UnitedKingdom #UnitedStates
-
Türkiye’s pharma sector sees over 8-fold surge in R&D spending
Türkiye’s pharma industry, one of the leading in the region and Europe, has seen a notable increase in…
#EuropeSays #Turkiye #Türkiye #pharmaindustry #pharmaceuticals #r&dspending #technology
https://www.europesays.com/turkiye/38433/ -
https://www.europesays.com/ie/631635/ Foundayo: Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill #BiotechAndPharmaceuticals #Business #BusinessNews #ConsumerStaplesSelectSectorSPDRFund #DavidARicks #DefianceDailyTarget2XLongLLYETF #Éire #EliLillyAndCo #Health #HealthCare #HealthCareIndustry #Healthcare #IE #Ireland #ISharesBiotechnologyETF #Medication #NovoNordiskA/S #pharmaceuticals #SpdrS&PBiotechEtf #UnitedStates
-
https://www.europesays.com/dk/143685/ Foundayo: Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill #BiotechAndPharmaceuticals #business #BusinessNews #ConsumerStaplesSelectSectorSPDRFund #DavidARicks #DefianceDailyTarget2XLongLLYETF #EliLillyAndCo #HealthCareIndustry #ISharesBiotechnologyETF #Medication #NovoNordisk #NovoNordiskA/S #Pharmaceuticals #SpdrS&PBiotechEtf #UnitedStates
-
https://www.europesays.com/people/184573/ Trump signs vaccine executive order calling for fewer childhood shots #BiotechAndPharmaceuticals #Biotechnology #BreakingNews:Business #Business #BusinessNews #DonaldJTrump #DonaldTrump #HealthCareIndustry #medication #Pharmaceuticals #RobertFKennedyJr #Trump
-
https://www.europesays.com/dk/143317/ Novo Nordisk updates 2026 share buyback totals | NVO SEC Filing #6KFiling #BShares #Denmark #DKK15Billion #NovoNordisk #NVO #Pharmaceuticals #ShareRepurchase #StockBuyback #TreasuryShares
-
https://www.europesays.com/ch/113711/ In surprise move, FDA rejects cancer drug expected to rival Novartis therapy #biotechnology #cancer #DrugDevelopment #Novartis #Pharmaceuticals #STAT+
-
Sanofi experiencing shortage of two Pompe disease drugs
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
#France #FR #Europe #EU #Sanofi #biotechnology #Pharmaceuticals #rarediseases #STAT+
https://www.europesays.com/france/63252/ -
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck. “For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about […]
https://rbfirehose.com/2026/08/09/venturebeat-stanford-is-running-37000-ai-agents-as-a-virtual-biotech-and-one-of-its-drug-designs-got-independently-confirmed-by-merck/ -
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck. “For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about […]
https://rbfirehose.com/2026/08/09/venturebeat-stanford-is-running-37000-ai-agents-as-a-virtual-biotech-and-one-of-its-drug-designs-got-independently-confirmed-by-merck/ -
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck. “For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about […]
https://rbfirehose.com/2026/08/09/venturebeat-stanford-is-running-37000-ai-agents-as-a-virtual-biotech-and-one-of-its-drug-designs-got-independently-confirmed-by-merck/ -
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck. “For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about […]
https://rbfirehose.com/2026/08/09/venturebeat-stanford-is-running-37000-ai-agents-as-a-virtual-biotech-and-one-of-its-drug-designs-got-independently-confirmed-by-merck/ -
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck. “For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about […]
https://rbfirehose.com/2026/08/09/venturebeat-stanford-is-running-37000-ai-agents-as-a-virtual-biotech-and-one-of-its-drug-designs-got-independently-confirmed-by-merck/ -
Britain’s pharma policy is a gift to Ireland
Share this article Here’s a fun fact for you: Ireland, a country of just over 5 million people,…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Brexit #ClinicalTrials #corporationtax #Drugpricing #industrialstrategy #INVESTMENT #Ireland #Lifesciences #MHRA #NHS #Pharmaceuticals #Regulation #VPAG
https://www.europesays.com/britain/99466/ -
https://www.europesays.com/britain/99466/ Britain’s pharma policy is a gift to Ireland #AstraZeneca #Brexit #Britain #ClinicalTrials #CorporationTax #DrugPricing #IndustrialStrategy #INVESTMENT #Ireland #LifeSciences #MHRA #NHS #Pharmaceuticals #Regulation #VPAG
-
FDA approves Reckitt’s new Mucinex cold, flu medicine
Reckitt has received approval from the U.S. Food and Drug Administration for a long-lasting cold and flu symptom-relief…
#EuropeSays #Britain #Europe #EU #ReckittBenckiser #coldandflu #consumerhealth #drugapproval #FDA #Mucinex #NewDrugApplication #Nutley #over-the-countermedication #Pharmaceuticals #Reckitt
https://www.europesays.com/britain/99301/ -
https://www.europesays.com/britain/99301/ FDA approves Reckitt’s new Mucinex cold, flu medicine #ColdAndFlu #ConsumerHealth #DrugApproval #FDA #Mucinex #NewDrugApplication #Nutley #OverTheCounterMedication #Pharmaceuticals #Reckitt #ReckittBenckiser
-
Pharmacist denies conflict of interest with man behind Essendon doping scandal
By Grace AttaA Darwin pharmacist is facing a tribunal over allegations he inappropriately dispensed performance-enhancing drugs and did so on the basis of a conflict of interest with the man at the centre of the Essendon football club doping scandal.
#DoctorsandMedicalProfessionals #Pharmaceuticals #Health #GraceAtta
-
Pharmacist denies conflict of interest with man behind Essendon doping scandal
By Grace AttaA Darwin pharmacist is facing a tribunal over allegations he inappropriately dispensed performance-enhancing drugs and did so on the basis of a conflict of interest with the man at the centre of the Essendon football club doping scandal.
#DoctorsandMedicalProfessionals #Pharmaceuticals #Health #GraceAtta
-
Pharmacist denies conflict of interest with man behind Essendon doping scandal
By Grace AttaA Darwin pharmacist is facing a tribunal over allegations he inappropriately dispensed performance-enhancing drugs and did so on the basis of a conflict of interest with the man at the centre of the Essendon football club doping scandal.
#DoctorsandMedicalProfessionals #Pharmaceuticals #Health #GraceAtta
-
Pharmacist denies conflict of interest with man behind Essendon doping scandal
By Grace AttaA Darwin pharmacist is facing a tribunal over allegations he inappropriately dispensed performance-enhancing drugs and did so on the basis of a conflict of interest with the man at the centre of the Essendon football club doping scandal.
#DoctorsandMedicalProfessionals #Pharmaceuticals #Health #GraceAtta
-
Pharmacist denies conflict of interest with man behind Essendon doping scandal
By Grace AttaA Darwin pharmacist is facing a tribunal over allegations he inappropriately dispensed performance-enhancing drugs and did so on the basis of a conflict of interest with the man at the centre of the Essendon football club doping scandal.
#DoctorsandMedicalProfessionals #Pharmaceuticals #Health #GraceAtta
-
On a GLP-1? There’s a vacation for that
Stamie Giallourakis was on her deathbed in early 2021 when she made herself a promise. At the time,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Exclusive #GLP-1 #Health #longevity #Ozempic #Pharmaceuticals #Resorts #travel #Vacations #weightloss #wellness
https://www.newsbeep.com/us/805298/ -
On a GLP-1? There’s a vacation for that
Stamie Giallourakis was on her deathbed in early 2021 when she made herself a promise. At the time,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Exclusive #GLP-1 #Health #longevity #Ozempic #Pharmaceuticals #Resorts #travel #Vacations #weightloss #wellness
https://www.newsbeep.com/us/805298/ -
Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little…
#NewsBeep #News #Healthcare #BiotechandPharmaceuticals #Biotechnology #BreakingNews:Business #Business #businessnews #EliLillyandCo #Health #Healthcareindustry #HealthCareSelectSectorSPDRFund #healthcare #iSharesBiotechnologyETF #iSharesU.S.PharmaceuticalsETF #NovoNordiskA/S #Pharmaceuticals #SpdrS&PBiotechEtf #UK #UnitedKingdom
https://www.newsbeep.com/uk/729592/ -
Natera seeks Japan’s PMDA approval for Signatera test in MIBC
Cell-free DNA and precision medicine company Natera has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency…
#EuropeSays #Japan #JP #bladdercancer #colorectalcancer #companiondiagnostic #MedicalDevicesAgency #MIBC #Natera #NationalComprehensiveCancerNetwork #Nihon #Pharmaceuticals #PMDA #precisionmedicine #Signateratest
https://www.europesays.com/japan/70073/ -
https://www.europesays.com/uk/1134292/ Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market #BiotechAndPharmaceuticals #biotechnology #BreakingNews:Business #Business #BusinessNews #EliLillyAndCo #Health #HealthCareIndustry #HealthCareSelectSectorSPDRFund #Healthcare #ISharesBiotechnologyETF #ISharesUSPharmaceuticalsETF #NovoNordiskA/S #Pharmaceuticals #SpdrS&PBiotechEtf #UK #UnitedKingdom
-
https://www.europesays.com/ie/623881/ Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market #BiotechAndPharmaceuticals #Biotechnology #BreakingNews:Business #Business #BusinessNews #Éire #EliLillyAndCo #Health #HealthCare #HealthCareIndustry #HealthCareSelectSectorSPDRFund #Healthcare #IE #Ireland #ISharesBiotechnologyETF #ISharesUSPharmaceuticalsETF #NovoNordiskA/S #pharmaceuticals #SpdrS&PBiotechEtf
-
https://www.europesays.com/dk/141511/ Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market #BiotechAndPharmaceuticals #Biotechnology #BreakingNews:Business #business #BusinessNews #EliLillyAndCo #HealthCareIndustry #HealthCareSelectSectorSPDRFund #ISharesBiotechnologyETF #ISharesUSPharmaceuticalsETF #NovoNordisk #NovoNordiskA/S #Pharmaceuticals #SpdrS&PBiotechEtf
-
https://www.europesays.com/britain/98623/ AstraZeneca-Bristol Myers merger talks explained #AstraZeneca #AstraZenecaPLC #BiotechAndPharmaceuticals #Biotechnology #BristolMyersSquibbCo #BusinessNews #DonaldTrump #GileadSciencesInc #HealthCareIndustry #ISharesBiotechnologyETF #ISharesUSPharmaceuticalsETF #Pharmaceuticals #SpdrS&PBiotechEtf #SpdrS&PPharmaceuticalsEtf #UnitedStates
-
https://www.europesays.com/ch/?p=112348 Roche expands cyclospora testing portfolio to support U.S. public health response #biotechnology #ClinicalTrials&MedicalDiscoveries #HealthCare&Hospitals #InfectionControl #MedicalPharmaceuticals #OTC #Pharmaceuticals #Roche #ROCHEDIAGNOSTICSCORPORATION #SmallCap
-
https://www.europesays.com/ch/112324/ Novartis India names Rahul Vijayvargiya as CHRO #CH:RO #CHROMovement #Employee #employees #employer #HR #Novartis #PharmaCompany #Pharmaceuticals #Rahul #RahulVijayvargiya #Recruitment #Vijayvargiya #Workforce #workplace
-
AstraZeneca-Bristol Myers merger talks explained
Pharma investors reeled this week fro…
#Bristol #UnitedKingdom #UK #GB #England #Headlines #News #Europe #EU #AstraZenecaPLC #BiotechandPharmaceuticals #biotechnology #Bristol-MyersSquibbCo #Britain #businessnews #DonaldTrump #GileadSciencesInc #GreatBritain #Healthcareindustry #iSharesBiotechnologyETF #iSharesU.S.PharmaceuticalsETF #Pharmaceuticals #SpdrS&PBiotechEtf #SpdrS&PPharmaceuticalsEtf #UnitedStates
https://www.europesays.com/uk/1133785/ -
Eli Lilly Makes a Strong Move, Novo Nordisk Gets the Upper Hand
Eli Lilly and Novo Nordisk are making significant moves in the pharmaceutical industry, highlighting competitive dynamics in drug development and market positioning.
#EU #Estonia #Pharmaceuticals #Business #Industry
https://www.aripaev.ee/borsiuudised/2026/08/05/eli-lilly-tegi-voimsa-huppe-novo-nordisk-sai-hoobi
-
Eli Lilly Makes a Strong Move, Novo Nordisk Gets the Upper Hand
Eli Lilly and Novo Nordisk are making significant moves in the pharmaceutical industry, highlighting competitive dynamics in drug development and market positioning.
#EU #Estonia #Pharmaceuticals #Business #Industry
https://www.aripaev.ee/borsiuudised/2026/08/05/eli-lilly-tegi-voimsa-huppe-novo-nordisk-sai-hoobi
-
Eli Lilly Makes a Strong Move, Novo Nordisk Gets the Upper Hand
Eli Lilly and Novo Nordisk are making significant moves in the pharmaceutical industry, highlighting competitive dynamics in drug development and market positioning.
#EU #Estonia #Pharmaceuticals #Business #Industry
https://www.aripaev.ee/borsiuudised/2026/08/05/eli-lilly-tegi-voimsa-huppe-novo-nordisk-sai-hoobi
-
CVS Health (CVS) earnings Q2 2026
CVS Health on Wednesday blew past second-quarter earnings and revenue estim…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #BiotechandPharmaceuticals #biotechnology #BreakingNews:Business #Business #businessnews #CVSHealthCorp #earnings #EliLillyandCo #Health #Healthcareindustry #HealthCareSelectSectorSPDRFund #iSharesU.S.HealthcareProvidersETF #Pharmaceuticals #VanguardHealthCareIndexFundETFShares
https://www.newsbeep.com/us/803556/ -
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
Erectile dysfunction drug may heighten risk of eye disease, study shows
By Lauren RobertsMen who take a widely-used erectile dysfunction drug to treat an enlarged prostate are "significantly more likely" to develop glaucoma, a new study has found.
-
Erectile dysfunction drug may heighten risk of eye disease, study shows
By Lauren RobertsMen who take a widely-used erectile dysfunction drug to treat an enlarged prostate are "significantly more likely" to develop glaucoma, a new study has found.
-
Erectile dysfunction drug may heighten risk of eye disease, study shows
By Lauren RobertsMen who take a widely-used erectile dysfunction drug to treat an enlarged prostate are "significantly more likely" to develop glaucoma, a new study has found.
-
Erectile dysfunction drug may heighten risk of eye disease, study shows
By Lauren RobertsMen who take a widely-used erectile dysfunction drug to treat an enlarged prostate are "significantly more likely" to develop glaucoma, a new study has found.
-
Novo Nordisk Exceeds Estimates and Raises Outlook
Novo Nordisk has surpassed earnings estimates and increased its financial outlook, signaling strong performance in the pharmaceutical sector.
#EU #Denmark #Pharmaceuticals #Finance #Economy
https://www.di.se/live/novo-nordisk-slar-estimaten-och-hojer-utsikter/
-
Novo Nordisk Exceeds Estimates and Raises Outlook
Novo Nordisk has surpassed earnings estimates and increased its financial outlook, signaling strong performance in the pharmaceutical sector.
#EU #Denmark #Pharmaceuticals #Finance #Economy
https://www.di.se/live/novo-nordisk-slar-estimaten-och-hojer-utsikter/
-
Novo Nordisk Exceeds Estimates and Raises Outlook
Novo Nordisk has surpassed earnings estimates and increased its financial outlook, signaling strong performance in the pharmaceutical sector.
#EU #Denmark #Pharmaceuticals #Finance #Economy
https://www.di.se/live/novo-nordisk-slar-estimaten-och-hojer-utsikter/
-
Novo Nordisk Exceeds Estimates and Raises Outlook
Novo Nordisk has surpassed earnings estimates and increased its financial outlook, signaling strong performance in the pharmaceutical sector.
#EU #Denmark #Pharmaceuticals #Finance #Economy
https://www.di.se/live/novo-nordisk-slar-estimaten-och-hojer-utsikter/
-
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
#NewsBeep #News #Medication #AU #Australia #Biotechnology #drugdevelopment #FDA #Health #Pharmaceuticals #Policy #STAT+
https://www.newsbeep.com/au/842747/ -
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #biotechnology #drugdevelopment #FDA #Health #Pharmaceuticals #Policy #STAT+
https://www.newsbeep.com/us/801938/
